All recalls
- 2026-04-09CPSCSilks, of Queen Creak, ArizonaSilks Recall Children's Loungewear Sets Due to Risk of Serious Injury or Death from Burn Hazard; Violates Mandatory Flammability Standards for Children's Sleepwear
The recalled children's loungewear violates mandatory flammability standards for children's sleepwear, posing a risk of serious injuries or deadly burn hazards to children.
- 2026-04-09CPSCSnooz, Inc., of Las Vegas, NevadaSNOOZ Recalls Electrical Fans Due to Fire Hazard
The power connector inside the fan can corrode and cause the fan to overheat, posing a risk of fire.
- 2026-04-09CPSCZhongshan Yungu Daily Products, of ChinaEasymake Adult Portable Bed Rails Recalled Due to Risk of Serious Injury or Death from Entrapment and Asphyxiation; Violates Mandatory Standard for Adult Portable Bed Rails; Imported by ZFZG-US
The recalled bed rails violate the mandatory standard for adult portable bed rails because users can become entrapped within the bed rail or between the bed rail and the side of the mattress, posing a serious entrapment hazard and risk of death by asphyxiation. In addition, the bed rails do not bear the required hazard warning labels.
- 2026-04-09CPSCVitaquest International LLC of West Caldwell, New JerseyVitaquest International Recalls Multiple Iron Supplement Bottles and Packets Due to Risk of Serious Injury or Death from Poisoning to Young Children; Violates Mandatory Standard for Child-Resistant Packaging
The dietary supplements contain iron, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the supplements is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- 2026-04-09CPSCBISSELL Homecare Inc. of Grand Rapids, MichiganBISSELL Recalls Over One Million Steam Shot OmniReach Steam Cleaners Due to Risk of Serious Burn Hazard from Attachments
The recalled steam cleaners' attachments can unexpectedly detach from the steam cleaners and expel hot water or steam onto users during use, posing a serious burn hazard.
- 2026-04-09CPSCWybotics, Co. Ltd. of Tianjin, ChinWybotics Recalls Robotic Pool Vacuums Due to Burn and Fire Hazards
The lithium-ion battery in the recalled pool vacuums can overheat, posing burn and fire hazards to consumers.
- 2026-04-08FDA-PRBlaine Labs, IncBlaine Labs, Inc Issues Voluntary Nationwide Recall of Wound Care Gel Products Due to Microbial Contamination
Santa Fe Springs, California – April 07, 2026 – Blaine Labs, Inc. is voluntarily recalling three (3) lot numbers of Wound Care Gel products, 1 oz. & 3 oz. (0.1% Benzalkonium Chloride) to the consumer level due to microbial contamination.
- 2026-04-08FDA-DeviceCardinal Health 200, LLCClass IICardinal Health Monoject Tuberculin Syringe, 1 mL Luer Lock, Catalog Number 1180100777
The outer packaging and blister pack labeling identify the product as 1mL Luer Lock Tuberculin Syringe (Product Code 1180100777), however the syringes contained within the packages are U-100 Insulin syringes.
- 2026-04-08FDA-DeviceGE Healthcare LLCClass IISIGNA Premier systems
Whole-Body MR scanners used to produce images of the inside of the human body to aid diagnosis of disease may have been manufactured/serviced with ferrous (steel) fittings instead of non-ferrous (brass) fittings on the magnet rear and if system is accessed to perform service while the magnet is ramped, the magnetic field could attract the ferrous fittings potentially resulting in personnel injury.
- 2026-04-08FDA-DeviceOxoid Australia Pty LimitedClass IIOXOID MICROBACT IDENTIFICATION KITS, Listeria 12L Kit, 20 Tests; Listeria identification sysystem
Oxoid Ltd., part of Thermo Fisher Scientific, confirmed that Microbact 12L Kit 20 Tests MB1128A lot 4494873 may identify incorrect organism due to inconclusive result from ambiguous color reactions in wells.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, Kilt Blockers.
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, Blockers.
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, Demi Half Aprons.
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, Half Aprons.
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, Leg Wraps.
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, Caps.
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, Protective Sleeves.
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, BAT (Breast, Axilla and Thyroid) Coverage.
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, Wrap Aprons.
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, Frontal Aprons
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, Kilt
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, Vest
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIBurlington Medical, Thyroid Shield.
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIParadigm REAL-Time Veo Insulin Pump (MMT-554, MMT-754)
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIMiniMed 530G Insulin Pump (MMT-551, MMT-751)
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIParadigm REAL-Time Revel Insulin Pump (MMT-523, MMT-723)
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIParadigm REAL-Time Insulin Pump (MMT-522, MMT-722)
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIParadigm Insulin Pump (MMT-712, MMT-715)
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIMiniMed 620G Insulin Pump (MMT-1750)
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIMiniMed 740G Insulin Pump (MMT-1811, MMT-1812, MMT-1861, MMT-1862)
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.